Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence.
Mendez Luque LF, Avelar-Barragan J, Nguyen H, Nguyen J, Soyfer EM, Liu J, Chen JH, Mehrotra N, Huang X, Kosiorek HE, Dueck A, Himstead A, Heide E, Lem M, El Alaoui K, Mas E, Scherber RM, Mesa RA, Whiteson KL, Odegaard A, Fleischman AG. Mendez Luque LF, et al. Among authors: lem m. Cancer Res Commun. 2024 Mar 5;4(3):660-670. doi: 10.1158/2767-9764.CRC-23-0380. Cancer Res Commun. 2024. PMID: 38391189 Free PMC article. Clinical Trial.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase.
Mendez Luque LF, Avelar-Barragan J, Nguyen H, Nguyen J, Soyfer EM, Liu J, Chen JH, Mehrotra N, Kosiorek HE, Dueck A, Himstead A, Heide E, Lem M, Alaoui KE, Marin EM, Scherber RM, Mesa RA, Whiteson KL, Odegaard A, Fleischman AG. Mendez Luque LF, et al. Among authors: lem m. medRxiv [Preprint]. 2023 May 12:2023.05.09.23289740. doi: 10.1101/2023.05.09.23289740. medRxiv. 2023. PMID: 37214789 Free PMC article. Updated. Preprint.
A Clinically Oriented antimicrobial Resistance surveillance Network (ACORN): pilot implementation in three countries in Southeast Asia, 2019-2020.
van Doorn HR, Miliya T, Douangnouvong A, Ta Thi Dieu N, Soputhy C, Lem M, Chommanam D, Keoluangkhot V, Soumphonphakdy B, Rassavong K, Thanadabouth K, Sayarath M, Chansamouth V, Vu MD, Dong PK, Dang VD, Tran VB, Do TKY, Ninh TN, Nguyen HL, Kim NH, Prak S, Vongsouvath M, Van DT, Nguyen TKT, Nguyen HK, Hamers RL, Ling C, Roberts T, Waithira N, Wannapinij P, Vu TVD, Celhay O, Ngoun C, Vongphachanh S, Pham NT, Ashley EA, Turner P. van Doorn HR, et al. Among authors: lem m. Wellcome Open Res. 2022 Dec 22;7:309. doi: 10.12688/wellcomeopenres.18317.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 37854668 Free PMC article.
Targeting Myofibroblasts as a Treatment Modality for Dupuytren Disease.
Ziegler ME, Staben A, Lem M, Pham J, Alaniz L, Halaseh FF, Obagi S, Leis A, Widgerow AD. Ziegler ME, et al. Among authors: lem m. J Hand Surg Am. 2023 Sep;48(9):914-922. doi: 10.1016/j.jhsa.2023.06.007. Epub 2023 Jul 20. J Hand Surg Am. 2023. PMID: 37480917
56 results